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Experiential avoidance has been defi ned as “the phenomenon 
that occurs when a person does not want to remain in contact with 
particular private experiences (e.g. bodily sensations, emotions, 
thoughts, memories, images, behavioral predispositions) and takes 
steps to alter the form or frequency of those experiences or the 
contexts that produce them” (Hayes, Wilson, Gifford, Follette, & 
Strosahl, 1996, p. 1154).
The importance of this construct is supported by research fi nding 
experiential avoidance to be a major factor in the development and 
maintenance of psychopathology. Several studies have pointed to 
the association between more experiential avoidance and greater 
interpersonal problems, as well as more severe psychopathology 
(García Montes, Luciano Soriano, Hernández López, & Zaldívar 
Basurto, 2004; Gerhart, Baker, Hoerger, & Ronan, 2014; 
Hershenberg, Mavandadi, Wright, & Thase, 2017; Kroska, Miller, 
Roche, Kroska, & O’Hara, 2018; Mellick, Vanwoerden, & Sharp, 
2017; Skinner, Rojas, & Veilleux, 2017; Spinhoven, Drost, de Rooij, 
van Hemert, & Penninx, 2015; Wagener, Baeyens, & Blairy, 2016). 
In addition, less experiential avoidance is associated with better 
well-being and quality of life (Álvarez Díaz & Esteve Zarazaga, 
2009; Hayes, Luoma, Bond, Masuda, & Lillis, 2006; Jacob, Ower, 
& Buchholz, 2013; Kashdan, Barrios, Forsyth, & Steger, 2006).
The fi rst instrument developed to measure experiential 
avoidance was the Acceptance and Action Questionnaire (AAQ; 
Hayes et al., 2004). A second version of this questionnaire, the 
Acceptance and Action Questionnaire II (AAQII; Bond et al., 
2011), was developed after the AAQ received criticism, especially 
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Abstract Resumen
Background: The Brief Experiential Avoidance Questionnaire (BEAQ) 
has been suggested as the most appropriate instrument for measuring 
experiential avoidance. However, no Spanish validation has been 
published. The aim of this study was to validate a Spanish version of the 
BEAQ in a clinical sample treated at a community mental health unit. 
Methods: Participants (N = 332) completed the BEAQ as well as other 
self-report measures of experiential avoidance and psychopathology. 
Results: Internal consistency was satisfactory (α = .82). No statistically 
signifi cant gender differences were found in the BEAQ scores. The data 
also showed high test-retest reliability after four to six weeks, acceptable 
concurrent validity with another experiential avoidance measure and 
acceptable convergent validity with the psychopathology measure. The 
principal component analysis, forcing the one factor solution proposed in 
the original scale, produced indicators similar to the English version of 
the BEAQ. Conclusions: These results fi rmly support the reliability and 
validity of this Spanish validation, stressing its usefulness as a measure of 
experiential avoidance in clinical populations.
Keywords: Experiential avoidance, Brief Experiential Avoidance 
Questionnaire, psychometric characteristics, assessment, clinical sample.
Validación de la versión española del Cuestionario Breve de Evitación 
Experiencial (BEAQ) en población clínica. Antecedentes: el 
Cuestionario Breve de Evitación Experiencial (BEAQ) ha sido propuesto 
como el instrumento más adecuado para medir la evitación experiencial. 
Sin embargo, todavía no ha sido publicada ninguna validación en español. 
Por lo tanto, el objetivo del presente estudio ha sido la validación de 
una versión española del BEAQ, en una muestra clínica atendida en un 
Centro de Salud Mental Comunitario. Método: los participantes (N = 
332) completaron el BEAQ, así como otras medidas de autoinforme de 
evitación experiencial y psicopatología. Resultados: la consistencia 
interna fue satisfactoria (α = .82). No se encontraron diferencias de 
género estadísticamente signifi cativas en las puntuaciones del BEAQ. 
Los datos también mostraron una alta fi abilidad test-retest en un intervalo 
de cuatro a seis semanas, validez concurrente aceptable con otra medida 
de evitación experiencial y validez convergente aceptable con la medida 
de psicopatología. El análisis de componentes principales forzando a 
la solución de un factor, como se propuso en la escala original, obtuvo 
unos indicadores similares a los obtenidos en dicha versión inglesa. 
Conclusiones: los resultados confi rman la adecuada fi abilidad y validez 
de la presente versión española del BEAQ, destacando su utilidad como 
medida de la evitación experiencial en población clínica.
Palabras clave: evitación experiencial, Cuestionario Breve de Evitación 
Experiencial, características psicométricas, evaluación, muestra clínica.
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concerning its low internal consistency (Cronbach’s alpha <.70), 
inadequate distinction between process and result (Chawla & 
Ostafi n, 2007), and poor discriminant validity with measures of 
negative affect and neuroticism. 
However, this second version has also been criticized for 
insuffi cient discriminant validity with measures of negative affect and 
neuroticism, especially in clinical samples (Gámez, Chmielewski, 
Kotov, Ruggero, Suzuki, & Watson, 2014). Thus, the AAQII is more 
correlated with measures of neuroticism and negative affect than 
with the AAQ or other avoidance measures (Gámez, Chmielewski, 
Kotov, Ruggero, & Watson, 2011). According to these authors, this 
is observed in the item content, which focuses, for example, on 
failed attempts at controlling discomfort and its consequences (e.g., 
“emotions cause problems in my life”; “worries get in the way of 
my success”). This can lead to criterion contamination (Gámez et 
al., 2011), since it confuses process with result.
Another criticism of both scales (AAQ and AAQII) is that the 
authors initially conceptualized them as measures of experiential 
avoidance, but later redefi ned their scope as psychological 
infl exibility. This construct includes some aspects of experiential 
avoidance, but also other concepts, such as cognitive fusion, lack 
of contact with values, lack of committed action and attention to 
the present (Bond et al., 2011), thereby exceeding the content of 
the experiential avoidance variable (Gámez et al., 2011).
The Multidimensional Experiential Avoidance Questionnaire 
(MEAQ; Gámez et al., 2011) was designed to overcome the 
limitations of both versions of the AAQ. It was intended as a 
comprehensible and reliable measure of experiential avoidance, 
differentiated from neuroticism. However, its length (62 items) 
made its applicability diffi cult in contexts where time is limited. 
The Brief Experiential Avoidance Questionnaire (BEAQ; Gámez 
et al., 2014) emerged as a brief, but still effective questionnaire. 
Its authors pointed out that this instrument manages to reduce the 
application time from 12 minutes on the full scale (MEAQ) to 3 
minutes. In addition, it covers content similar to the MEAQ and 
both scales show practically the same convergent and discriminant 
association. Because of the limitations of those already mentioned 
above (AAQ, AAQII and MEAQ), it has been suggested that this 
brief version, the BEAQ, is the most appropriate instrument for 
measuring experiential avoidance (Wolgast, 2014). However, no 
Spanish validation has yet been published.
Due to the relevance of the experiential avoidance construct 
and its negative association with wellbeing and health measures, 
we consider the validation of this instrument in Spanish population 
to be of great importance. The purpose of the present research was 
to analyze the psychometric properties of a Spanish version of the 
BEAQ in a clinical sample.
Method
Participants
The sample consisted of 332 patients treated in a community 
mental health unit. It included 228 women (69%) and 104 men 
(31%). All the participants were Caucasian and were aged between 
18 and 78 years (M = 45.97, SD = 12.44). The inclusion criteria 
were: 1) have been diagnosed with a mental disorder according 
to ICD-10 (World Health Organization, 1992), specifi cally those 
corresponding to Depressive Disorder (F32.0, F32.1, F33.0 and 
F33.1), Dysthymia (F34.1), Anxiety Disorder (F40 and F41), 
Obsessive-Compulsive Disorder (F42), Adjustment disorders (F43), 
Eating Disorder (F50) and Personality Disorder (F60); 2) be of 
legal age; 3) have no cognitive impairment; 4) give their voluntary 
consent to participation in the study. Other sociodemographic and 
clinical data appear in Table 1. 
Instruments
Brief Experiential Avoidance Questionnaire (Gámez et al., 
2014). This is a self-report questionnaire with 15 items that measure 
experiential avoidance. The items are rated on a 6-point Likert 
scale (1=”strongly disagree” to 6=”strongly agree”). The scores 
range from 15 to 90 points (item 6 must be inverted), with higher 
scores showing greater experiential avoidance. In its original 
version, the BEAQ shows association with measures of avoidance, 
psychopathology and quality of life, as well as it shows strong 
convergence with each of the six dimensions of the MEAQ (Gámez 
et al., 2011), the original scale which the items for this short version 
were extracted from. The English version has good reliability, with 
a Cronbach’s alpha of .80 to .89 for the various samples. 
Acceptance and Action Questionnaire II (Bond et al., 2011). 
This is a self-report scale with seven items measuring experiential 
avoidance. The items evaluate unwillingness to experience 
Table 1
Sociodemographic information (N = 332) 
Variables N %
Marital Status
Single 109 32.8
Married/domestic partner 147 44.3
Separated/Divorced   45 13.6
Widowed
Unknown
   6
  25
 1.8
 7.5
Total 332 100
Educative level
Primary school   37 11.1
Secondary School   44 13.3
Secondary school certifi cate/Professional training   92 27.7
University 126 38
Unknown
Total
  33
332
9.9
100
Employment
Working 169 50.9
Unemployed   67 20.3
Pensioned   20  6
Retired    6  1.8
Student   27  8.1
Homemaker
Other
  20
  23
 6
 6.9
Total 332 100
Primary Diagnostics
Depression  41 12.3
Anxiety 117 35.3
Adjustment Disorder
Eating Disorder
Personality Disorder
125
 30
 19
37.7
  9
  5.7
Total 332 100
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unwanted emotions, thoughts and feelings and the inability to act 
according to values on a 7-point Likert scale (1=”never true” to 
7=”always true”). Scores range from 7 to 49, with higher scores 
showing higher experiential avoidance. The Spanish version used 
(Ruiz, Langer Herrera, Luciano, Cangas, & Beltrán, 2013) has 
acceptable internal consistency, with a Cronbach’s alpha of .75 for 
a sample of clinical patients. 
Symptoms Checklist-90-Revised (SCL-90-R; Derogatis, 1977). 
This self-report scale is composed of 90 items covering a wide 
variety of psychopathological manifestations. The nine dimensions 
evaluated are somatization, obsessive-compulsive, interpersonal 
sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid 
ideation and psychoticism. The results offer a symptomatic 
profi le as well as three global indexes: global severity index, total 
positive symptoms and positive symptom distress index. The 
items are scored on a scale of 5-point Likert scale (0 =”not at all” 
to 4 =”very or extremely”), based on the intensity with which a 
series of symptoms were experienced during the previous week. 
The Spanish adaptation used (González de Rivera, de las Cuevas, 
Rodríguez-Abuin, & Rodríguez-Pulido, 2002) has a Cronbach’s 
alpha coeffi cient of .94 for the 90 elements included in the test. 
Procedure
First, following guidelines for test validation (Muñiz, Elosua, 
& Hambleton, 2013), authorization was requested from the main 
author of the BEAQ scale for its translation and validation in 
a Spanish sample. With his permission, it was translated into 
Spanish by the reverse translation method. This scale was applied 
to a pilot sample of six patients to make sure they understood it, 
and it was unnecessary to make any changes in the items. Due to 
the length of the questionnaire, the SCL-90-R was applied only 
to the fi rst 112 participants. This research was approved by the 
Andalusian Biomedical Research Ethics Committee. 
Data analysis
First, the Kaiser-Meyer-Olkin and the Barlett’s sphericity 
test analysis were performed to fi nd out whether the items were 
correlated and adequate for factor analysis. To determine the 
factor loadings, an analysis of principal component analysis was 
carried out, specifying a one-factor solution as proposed by the 
authors of the original scale.
Furthermore, a descriptive analysis of the items on this Spanish 
version of the BEAQ was carried out by calculating measures of 
central tendency and dispersion. Skewness and kurtosis were 
calculated as well to determine the behavior of the data found 
from the questionnaire. Next, the normal distribution of data 
was checked with the Kolmogorov-Smirnov test of normality. 
The Student’s t test was also calculated for any possible gender 
differences in the scores. 
Internal consistency of the BEAQ was then calculated using 
the Cronbach’s alpha coeffi cient, and Omega coeffi cient was used 
to examine its factorial reliability (Dunn, Baguley, & Brunsden, 
2014; Elosua & Zumbo, 2008; Ventura-León & Caycho-
Rodríguez, 2017). In addition, temporal reliability was analyzed 
with the Pearson’s r correlation of the measure at two different 
times four to six weeks apart. Finally, the instrument’s sources 
of validity were analyzed (Muñiz, 2018). First, the concurrent 
validity of the BEAQ with the AAQII was calculated, using the 
Pearson’s r correlation coeffi cient. An analysis of convergent 
validity of experiential avoidance with the SCL-90-R, a general 
psychopathology measure, was performed using the Pearson’s 
correlation. Specifi c correlation with the global severity index, 
as well as with fi ve of its subscales (anxiety, depression, phobic 
anxiety, somatization and obsessive-compulsive), were also 
explored. Statistical analyses were performed using SPSS v.21. 
Results
Sources of validity evidence of internal structure
The Kaiser-Meyer-Olkin test for sample adequacy (KMO = 
.83) and the Barlett’s sphericity test (X2 = 1251.87, p < .01) both 
confi rmed adequacy of the sample data for factor analysis. A 
principal component analysis was done, forcing a one-factor 
solution, as proposed in the original scale. The fi rst fi ve eigenvalues 
were 4.52, 1.57, 1.11, 1.08 and .94. The component extracted 
explained 30.12% of the variance. Table 2 shows the saturation of 
each item on this single component.
Descriptive statistics
The descriptive characteristics of the BEAQ in the sample are 
presented in Table 3. The Kolmogorov-Smirnov normality test 
confi rmed that the distribution of the BEAQ scores followed a normal 
distribution, at a signifi cance level over .05 (Z = .864, p = .445).
The Student t test for independent samples showed absence of 
signifi cant differences in the scores on experiential avoidance (t = 
.103, p = .92) between women (M = 55.54, SD = 13.40) and men 
(M = 55.72, SD = 15.04). The effect size, calculated by Cohen’s d, 
was insignifi cant (d = 0.013).
Reliability of the scores
Internal consistency. The Cronbach’s alpha was .82, which 
shows high internal consistency of the instrument. Table 4 shows 
the means and variance in the scale if the item was eliminated, as 
Table 2
Saturation for the items on the BEAQ after principal 
component analysis for a one-factor solution (N = 332)
Item Nº Factorial loadings
1 .55
2 .56
3 .33
4 .43
5 .55
6 .26
7 .57
8 .61
9 .44
10 .68
11 .61
12 .71
13 .57
14 .63
15 .56
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well as the corrected item-total correlation and Cronbach’s alpha 
when each item of the scale is eliminated. The corrected item-total 
correlation was over .35 for 13 of the 15 items, which is adequate 
and signifi cant according to Cohen and Manion (1989). The two 
exceptions were Items 3 and 6, which had a correlation with the 
total scale of r = .24 and r = .21, respectively. Because of these 
results, the Cronbach’s alpha was calculated for the scale after 
eliminating these items. By eliminating Item 3, Cronbach’s alpha 
remained at .82 and only rose slightly when Item 6 was eliminated, 
from .82 for the total items to .83. In no case would eliminating 
any of the remaining items improve the Cronbach’s alpha for the 
total scale. Omega index was .86, also supporting the adequate 
factorial reliability of the scale.
Temporal reliability. The results showed a high positive 
correlation (r = .70, p < .01) between the BEAQ before and after 
an interval of 4-6 weeks (N = 48). This shows high temporal 
reliability of the Spanish version of the instrument with a clinical 
population.
Sources of validity evidence in relation with other variables
The concurrent validity between the BEAQ and the AAQII, 
analyzed using the Pearson’s correlation, was signifi cant with 
r = .67 (p < .01). To analyze the convergent validity of the 
BEAQ experiential avoidance scale with other psychopathology 
measures, both the symptom inventory SCL-90-R (Derogatis, 
1977) global severity index, and fi ve of that instrument’s subscales 
(anxiety, depression, phobic anxiety, somatization and obsession-
compulsion) were used. The Pearson correlation analyses for the 
indicators above showed signifi cant correlations for the global 
BEAQ score in all cases. The results are shown in Table 5.
Table 3
Descriptive statistics (N = 332) 
Item Nº BEAQ Mean SD Skewness Kurtosis
1 3.24 1.84 0.10 -1.48
2 3.55 1.70 -0.08 -1.30
3 4.00 1.64 -0.36 -1.09
4 2.78 1.75 0.47 -1.24
5 3.64 1.85 -0.12 -1.46
6 3.45 1.85 0.05 -1.47
7 4.12 1.74 -0.54 -1.07
8 3.32 1.70 0.11 -1.31
9 3.43 1.84 0.01 -1.45
10 4.09 1.74 -0.50 -1.10
11 4.46 1.56 -0.82 -0.44
12 4.03 1.71 -0.45 -1.10
13 4.14 1.53 -0.49 -0.82
14 3.17 1.67 0.28 -1.16
15 4.17 1.81 -0.50 -1.21
Total 55.60 13.92 -0.24 -0.27
Table 4
Internal consistency, item-total statistics (N = 332)
Item Nº 
BEAQ
Scale mean 
if item is 
deleted
Scale 
variance 
if item is 
eliminated
Corrected 
total-item 
correlation
 Cronbach’s 
alpha if item 
is eliminated
1 52.36 168.91 .45 .81
2 52.05 170.17 .46 .81
3 51.60 180.22 .24 .82
4 52.82 173.54 .37 .82
5 51.96 167.94 .47 .81
6 52.15 179.64 .21 .83
7 51.48 169.55 .47 .81
8 52.28 168.84 .50 .81
9 52.17 172.99 .36 .82
10 51.51 164.95 .58 .80
11 51.14 171.08 .50 .81
12 51.57 164.22 .61 .80
13 51.46 173.40 .45 .81
14 52.43 167.94 .53 .81
15 51.42 168.77 .46 .81
Table 5
Convergent validity. Pearson correlations between BEAQ and SCL-90-R 
global severity index and subscales
SCL-90-R N BEAQ
Anxiety 112 .34**
Depression 110 .46**
Phobic anxiety 110 .35**
Somatization 109 .27**
Obsesive-Compulsive 109 .43**
Global Severity Index 96 .48**
** p< .01
Appendix
Brief Experiential Avoidance Questionnaire
Please indicate the extent to which you agree or disagree with each of the following 
statements (1= Strongly disagree; 6= Strongly agree)
1. The key to a good life is never feeling any pain [La clave para vivir bien es no sentir 
nunca ningú n dolor]
2. I’m quick to leave any situation that makes me feel uneasy [Rá pidamente dejo 
cualquier situació n que me haga sentir mal]
3. When unpleasant memories come to me, I try to put them out of my mind [Cuando se 
me vienen a la mente recuerdos desagradables, trato de desecharlos]
4. I feel disconnected from my emotions [Me siento desconectado/a de mis emociones]
5. I won’t do something until I absolutely have to [No me pongo a hacer algo hasta que 
no me veo totalmente obligado/a a hacerlo]
6. Fear or anxiety won’t stop me from doing something important [El miedo o la ansiedad 
no me impedirá n hacer las cosas importantes]
7. I would give up a lot not to feel bad [Renunciarí a a muchas cosas con tal de no 
sentirme mal]
8. I rarely do something if there is a chance that it will upset me [Difícilmente hago algo 
si hay alguna posibilidad de que me desagrade]
9. It’s hard for me to know what I’m feeling [Es difí cil para mí saber lo que estoy 
sintiendo]
10. I try to put off unpleasant tasks for as long as posible [Trato de retrasar todo lo posible 
las tareas que son desagradables]
11. I go out of my way to avoid uncomfortable situations [Me esfuerzo en evitar situaciones 
desagradables]
12. One of my big goals is to be free from painful emotions [Uno de mis mayores objetivos 
es estar libre de cualquier emoció n dolorosa]
13. I work hard to keep out upsetting feelings [Me esfuerzo mucho para evitar las 
sensaciones desagradables]
14. If I have any doubts about doing something, I just won’t do it [Si tengo cualquier duda 
al hacer una cosa, dejo de hacerla]
15. Pain always leads to suffering [El dolor siempre lleva al sufrimiento]
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Discussion
The results of this study show adequate psychometric properties 
of the Spanish adaptation of the BEAQ in a clinical population 
and advise its use as a measure of experiential avoidance in this 
context. Furthermore, in general terms, it could be said that this 
adaptation achieves psychometric characteristics similar to those 
refl ected by the authors in the original English version of the 
BEAQ (Gámez et al., 2014).
The mean of the total score in the Spanish sample is 55.60. 
This is very similar to the two clinical samples analyzed with the 
original English instrument (M = 56.41 and M = 52.03, respectively). 
The standard deviation (SD = 13.92) is also similar to the original 
instrument (SD = 12.64 and SD = 12.23, respectively). 
This Spanish adaptation has good internal consistency (α = 
.82), which in turn is similar to the α = .83 found by Gámez et 
al. (2014) in their clinical population. This result supports the 
homogeneity of the scale and the contribution of all the items to 
the measurement of the experiential avoidance construct in the 
Spanish version analyzed.
However, if the correlation of each item with the total scale is 
analyzed in detail, lower scores are observed on Items 3 and 6, with 
correlations of .24 and .21, respectively, when .35 is considered 
advisable for signifi cant correlation with the total scale (Cohen 
& Manion, 1989). This suggests lower contribution of the items 
to the construct to be measured. Item 3 contains the statement 
“When unpleasant memories come to me, I try to put them out of 
my mind”. Because of this non-signifi cant correlation, the internal 
consistency of the scale was tested again without Item 3, but the 
Cronbach’s alpha for the scale did not increase, remaining at .82. 
So the item was kept to maintain the greatest possible similarity 
with the original scale. 
The Cronbach’s alpha for the scale was also analyzed without 
Item 6, “Fear or anxiety won’t stop me from doing something 
important”. However, as it only increased slightly from .82 to .83, 
it was decided to keep Item 6 for its content representation, as did 
the authors of the BEAQ.
The temporal reliability of the BEAQ, after 4 to 6 weeks was 
high (r = .70, p < .01), showing that its measure of the experiential 
avoidance construct is stable over time. This contribution of 
temporal reliability is of special interest because there is no 
information on it in the original English version.
Concurrent validity of the BEAQ is shown by its signifi cant 
correlation with another avoidance measure, the AAQII (r = .67, 
p < .01). In the original English version, they found a signifi cant 
correlation between these two scales in their sample of students (r = 
.61, p < .01), and a non signifi cant correlation in the two samples of 
patients (r = .62 and r = .63, respectively). However, despite the fact 
that the correlation is not signifi cant in any of these two samples, 
the authors of the original version concluded that the BEAQ’s 
correlation with other avoidance measures was stronger than its 
correlation with other measures of negative emotionality. It should 
be recalled that this was one of their main objectives, specifi cally, 
that the instrument should be a reliable and valid measure of 
experiential avoidance differentiated from other associated 
constructs, such as neuroticism. Thus, it may be concluded that 
in this study, the data also support the validity of the BEAQ as 
a measure of experiential avoidance by confi rming its correlation 
with another measure of experiential avoidance, the AAQII.
In relation to the convergent validity of the BEAQ with the 
measures of psychopathology measured by the SCL-90-R, it is 
noteworthy that all were signifi cant at p < .01. This is also consistent 
with the result for the original scale. In their study, Gámez et al. 
(2014) pointed out robust relationships between the BEAQ and 
various scales of psychopathology, among which are measures of 
depression, situational phobia and obsession-compulsion.
Based on these results, it may be observed, as in the original 
instrument, that the BEAQ showed moderate correlations with 
indicators of negative emotionality (mean r = .39), but stronger 
correlation with a measure of experiential avoidance (r = .67). 
Thus, the Spanish adaptation also achieves the objective of the 
authors of the original instrument of measuring experiential 
avoidance as discriminated from negative emotionality. These 
results therefore support the validity of the BEAQ as a measure of 
the experiential avoidance construct.
The results of factor analysis were similar to those for the 
English version. Using principal compoment analysis and forcing 
one factor like the original scale, 30.12% of the variance was 
explained. This percentage is very similar to the one presented 
by Gámez et al. (2014), who reported 28.98% as the variance 
explained by the factor. The fi rst fi ve eigenvalues in the Spanish 
sample were 4.52, 1.57, 1.11, 1.08 and .94, respectively. 
Similar to this study, in a fi rst sample of patients who were 
administered the English version, Item 6 had the lowest factor 
loading, which was -.33. The rest of the factor loadings were .38 
to .63. It might be thought that because Item 6 was included to 
cover specifi c content in the MEAQ questionnaire, despite having 
an initial factor loading of less than .40, this means that in our 
sample the same trend is maintained, and that therefore, the 
loading on the factor is lower. On the other hand, Item 3, “When 
unpleasant memories come to me, I try to put them out of my 
mind “, also had a lower factor loading (.33) than the rest of the 13 
items with signifi cant loadings. This coincides with the fi ndings 
by Gámez et al. (2014), who also found this item to have one of 
the lowest factor loadings. But in this case, it was signifi cant. In 
view of the results above, we can affi rm that the scale fi ts to the 
one-factor solution, similar to the one proposed by the authors of 
the original version.
Regarding limitations, it should be noted that the data was 
collected exclusively through self-reported measures, so they 
are vulnerable to possible biases associated with the use of a 
single method (Podsakoff, MacKenzie, Lee, & Podsakoff, 2003). 
Thus, it would be important to validate the BEAQ data with 
those found by other methods, such as professional evaluation 
of the patient concerning the experiential avoidance construct. 
Another limitation was the non-randomized sample. Therefore, 
the sample could not be representative of the Spanish population 
with clinical disorders. Moreover, the diagnosis is not based on a 
structured interview, but on the clinical judgement of a clinical 
psychologist or psychiatrist after a clinical interview based on 
the ICD-10 diagnostic criteria. Besides, the study does not use an 
infrequency response scale to identify dishonest or non-compliant 
participants. 
Future research should confi rm the factor structure with 
confi rmatory factor analysis in a larger sample. In addition, the 
psychometric characteristics of the present scale should be studied 
in a Spanish clinical population with other psychopathological 
disorders, as well as in the general population.
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In view of the results of this study, we can conclude by 
highlighting the adequate psychometric characteristics of this 
Spanish adaptation of the BEAQ. These good results support the 
use of the BEAQ as an instrument for measuring experiential 
avoidance in a Spanish clinical population, and is therefore a 
relevant contribution providing a short form (approximately 3 
minutes) of the instrument considered the most appropriate at 
present for measuring experiential avoidance (Wolgast, 2014) 
in various clinical contexts. This enables its administration in 
care contexts where time management and limited resources 
prioritize instruments that take a short time for their 
application.
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